MENU
ITOC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ITOC stock forecast, quote, news & analysis

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment... Show more

ITOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for ITOC with price predictions
Sep 11, 2026

Momentum Indicator for ITOC turns negative, indicating new downward trend

ITOC saw its Momentum Indicator move below the 0 level on September 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator turned negative. In 30 of the 31 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ITOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for ITOC just turned positive on August 27, 2026. Looking at past instances where ITOC's MACD turned positive, the stock continued to rise in 12 of 13 cases over the following month. The odds of a continued upward trend are 90%.

ITOC moved above its 50-day moving average on September 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ITOC crossed bullishly above the 50-day moving average on August 31, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +18.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where ITOC advanced for three days, in 76 of 81 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 30 of 30 cases where ITOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.844) is normal, around the industry mean (10.685). P/E Ratio (0.000) is within average values for comparable stocks, (67.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.653). ITOC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (9.294) is also within normal values, averaging (35.925).

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. ITOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ITOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.46B. The market cap for tickers in the group ranges from 1.86K to 176.41B. ABT holds the highest valuation in this group at 176.41B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -5%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -7%. TNON experienced the highest price growth at 59%, while CTSO experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 73%. For the same stocks of the Industry, the average monthly volume growth was 37% and the average quarterly volume growth was 12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 75
Price Growth Rating: 62
SMR Rating: 89
Profit Risk Rating: 95
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
ITOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details
Industry
N/A
Address
No. 8 Beiyuan Xiaojie
Phone
+86 1084817665
Employees
7
Web
http://www.ftzy.com.cn
Momentum Indicator for ITOC turns negative, indicating new downward trend